References

1. Ginsburg GS et al. Health Aff (Millwood) 2018; 37: 694–701.

2. Nesline MK et al. Oncotarget 2019; 10: 4616–4629.

3. Van der Velden DL et al. Nature 2019 [Epub ahead of print].

4. Hainsworth JD et al. J Clin Oncol 2018; 36: 536–542.

5. Reitsma M et al. J Manag Care Spec Pharm 2019; 25: 601–611.

6. Signorovitch J et al. J Clin Oncol 2017; 35 (Suppl 15): 6599–6599.

7. Conway J Marino I. Am J Manag Care 2016; 22 (Suppl 12): SP439–SP443.

8. Frampton GM et al. Nat Biotechnol 2013; 31: 1023–1031.

9. FoundationOne®CDx Technical Specifications, 2018. Available at: www.rochefoundationmedicine.com/f1cdxtech (Accessed October 2019).

10. FoundationOne®Liquid Technical Specifications, 2018. Available at: https://www.foundationmedicine.com/genomic-testing/foundation-one-liquid (Accessed October 2019).

11. FoundationOne®Heme Technical Specifications, 2019. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme. (Accessed October 2019).

12. He J et al. Blood 2016; 127: 3004–3014.

13. Dy GK et al. BMC Med Informatics and Decision Making 2019; 19: 14.

14. Rodriguez-Rodriguez L et al. Gyneacol Oncol 2016; 141: 2–9.

15. Lee H and Ross JS. Ther Adv Gastroenterol 2017; 10: 507–520.

16. Wheler J et al. Cancer Res. 2014 74: 7181–7184.

17. Schwaederle M, Kurzrock R. Oncoscience 2015; 2: 779–780.

18. Barlesi F et al. Lancet 2016; 87: 1415–1426.

19. Schwaederle M et al. J Clin Oncol 2015 ;33: 3817–3825.

20. Jardim DLF et al. J Natl Cancer Inst 2015; 107: djv253.

21. ASCO Meeting Library. Available at: https://www.embase.com using the search string ('clinical trial' OR 'clinical study') AND ('profiling' OR 'targeted therapy') AND '2018 annual meeting of the american society of clinical oncology, asco':nc. (Accessed October 2019).

22. Precision Oncology Knowledge Base. Available at: http://oncokb.org/#/actionableGenes. (Accessed October 2019).

23. National Cancer Institute. Targeted cancer therapies. Available at: https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet#what-targeted-therapies-have-been-approved-for-specific-types-of-cancer. Accessed October 2019.

24. Trinity partners. ‘Oncology Basket Trials: An Emerging Paradigm Shift in Trial Design & Treatment Approach?’ May 2018. Available at: http://trinitylifesciences.com/wp-content/uploads/2019/05/Oncology_Basket_Trials_-_Trinity_Partners.pdf. Accessed October 2019).

25. Suh JH et al. Oncologist 2016; 21: 684–691.

26. Sicklick JK et al. Nat Med 2019; 25: 744–750.

27. Dong L et al. Curr Genomics 2015; 16: 253–263.

28. Merker JD et al. J Clin Oncol 2018; 36: 1631-1641.

29. Jennings LJ et al. J Mol Diagn 2017; 19: 341–345.

30. Rankin A et al. Oncologist 2016; 21: 1306–1314.

31. Anhorn R et al. Value Health 2017; 20: A575.

32. van der Velden DL et al. Ann Oncol 2017; 28: 3070–3075.

33. Willemsen AECAB et al. Br J Cancer 2019; 121: 34–36.

34. Bourret P and Cambrosio A. Sociology of Health & Illness/ Early View 2019; doi: 10.1111/1467-9566.12970 [Epub ahead of print].

35. Rolfo C et al. ESMO Open 2018; 3: e000398.

36. van der Haar J et al. ESMO Open 2019; 4: e000516.

37. Charara RN et al. J Glob Oncol 2016; 3: 242–249.

38. Pennell NA et al. J Clin Oncol 2018; 36: 9031.

39. Haslem DS et al. J Oncotarget 2018; 9:12316–22.

40. FoundationOne®CDx clinical validation, 2017. Available at: http://www.foundationmedicine.com/genomic-testing/foundation-one-cdx. (Accessed October 2019).

41. Next Generation Sequencing (NGS) guidelines for somatic genetic variant detection, 2015. Available at: https://www.wadsworth.org/sites/default/files/WebDoc/1300145166/NextGenSeq_ONCO_Guidelines.pdf (Accessed October 2019).

42. Roche FoundationOne®CDx FDA Approval press release, 2017. Available at: https://www.roche.com/media/store/releases/med-cor-2017-12-04.htm. (Accessed October 2019).

43. A search for "Foundation Medicine"[Affiliation] on the NCBI database resulted in 434 publications, as of October 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed. Accessed October 2019.

44. Foundation Insights. Available at: foundationmedicine.com/insights-and-trials/foundation-insights (Accessed August 2019).

45. FoundationOne®CDx Sample report 2018. Available at: www.rochefoundationmedicine.com/reporting (Accessed October 2019).